Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats

Psychoneuroendocrinology

Volumn 24, Issue 3, 1999, Pages 301-311

  Bluthé, Rose Marie ^a   Castanon, Nathalie ^a   Pousset, Florence ^a   Bristow, Adrian ^b   Ball, Chris ^b   Lestage, Jacques ^a   Michaud, Bruno ^a   Kelley, Keith W ^c   Dantzer, Robert ^a  

^a INSERM   (France)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c Dept of Food Sci and Hum Nutr   (United States)

Author keywords

Activity; Body weight; Cytokine; Interleukin 10; Lipopolysaccharide; Rats Brain; Social behaviour

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 10;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE TIME EFFECT RELATION; EXPLORATORY BEHAVIOR; IMMOBILIZATION; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; REGULATORY MECHANISM; SOCIAL INTERACTION; WEIGHT REDUCTION;

ANIMALS; BEHAVIOR, ANIMAL; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 0033054058     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(98)00077-8     Document Type: Article

References (38)

1. Berg D.J., Kühn R., Rajewsky K., Müller W., Menon S., Davidson N., Grünig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Schartzman Reaction but not endotoxin tolerance. J. Clin. Invest. 96:1995;2339-2347.
2. Bjork L., Andersson J., Ceska M., Andersson U. Endotoxin and Staphylococcus aureus enterotoxin A induce different patterns of cytokines. Cytokine. 4:1992;513-519.
3. Bluthé R.-M., Dantzer R., Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 573:1992;318-320.
4. Breder C.D., Hazuka C., Ghayur T., Klug C., Huginin M., Yasuda K., Teng M., Saper C.B. Regional induction of tumor necrosis factor α expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. USA. 91:1994;11393-11397.
5. Dantzer R., Bluthé R.-M., Aubert A., Goodall G., Bret-Dibat J.-L., Kent S., Goujon E., Layé S., Parnet P., Kelley K.W. Cytokines actions on behavior. Rothwell N.J. Cytokines in the Nervous System. 1996;117-144 Landes, Biomedical Publishers, Austin.
6. Diab A, Zhu J., Xiao B.G., Mustafa M., Link H. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J. Neuropathol. Exp. Neurol. 56:1997;641-650.
7. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 112:1997a;321S-329S.
8. Dinarello C.A. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J. Biol. Regul. Homeostatic Agents. 11:1997b;91-103.
9. Di Santo E., Sironi M., Pozzi P., Gnocchi P., Isetta A.M., Delvaux A., Goldman M., Marchant A., Ghezzi P. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1β production in the brain without affecting the activation of the hypothalamus-pituitary-adrenal axis. Neuroimmunomodulation. 2:1995;149-154.
10. Di Santo E., Adami M., Bertorelli R., Ghezzi P. Systemic interleukin-10 administration inhibits brain tumor necrosis factor production in mice. Eur. J. Pharmacol. 336:1997;197-202.
11. Frei K., Lins H., Schwerdel C., Fontana A. Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152:1994;2720-2728.
12. Gatti S., Bartfai T. Induction of tumor-necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 624:1993;291-294.
13. Gérard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers D., Goldman M., Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:1993;547-550.
14. Hagenbaugh A., Sharma S., Dubinett S.M., Wei S.H.-Y., Aranda R., Cheroutre H., Fowell D.J., Binder S., Tsao B., Locksley R.M., Moore K.W., Kronenberg M. Altered immune response in interleukin 10 transgenic mice. J. Exp. Med. 185:1997;2101-2110.
15. Howard M., O'Garra A. Biological properties of interleukin 10. Immunol. Today. 13:1992;198-200.
16. Huettner C., Paulus W., Roggendorf W. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol. 146:1995;317-322.
17. Jander S, Pohl J., D'Urso D., Gillen C., Stoll G. Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am. J. Pathol. 152:1998;975-982.
18. Kasai T., Inada K., Takakuwa T., Yamada Y., Inoue Y., Shimamura T., Taniguchi S., Sato S., Wakabayashi G., Endo S. Anti-inflammatory cytokine levels in patients with septic shock. Res. Commun. Mol. Pathol. Pharmacol. 98:1997;34-42.
19. Kent S., Bluthé R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13:1992;24-28.
20. Kent S., Bret-Dibat J.L., Kelley K.W., Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 20:1996;171-175.
21. Lalani I., Bhol K., Ahmed A.R. Interleukin-10: biology, role in inflammation and autoimmunity. Ann. Allergy Asthma Immunol. 79:1997;469-483.
22. Layé S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Mol. Brain Res. 27:1994;157-162.
23. Lodge P.A., Sriram S. Regulation of microglial activation by TGF-β, IL-10 and CSF-1. J. Leukocyte Biol. 60:1996;502-508.
24. Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gérard C., Delvaux A., De Groote D., Abramowicz D., Velu T., Goldman M. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1994;1167-1171.
25. Marie C., Cavaillon J-M. Le rétrocontrôle négatif de l'inflammation: rôle des cytokines antiinflammatoires. Bull. Inst. Pasteur. 95:1997;41-54.
26. Minghetti L., Polazzi E., Nicolini A., Levi G. Opposite regulation of prostaglandin E2 synthesis by transforming growth factor-β1 and interleukin-10 in activated microglial cultures. J. Neuroimmunol. 82:1998;31-39.
27. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 205:1994;1907-1915.
28. Moldawer L.L., Gelin J., Schersten T., Lundholm K.G. Circulating interleukin-1 and tumor necrosis factor during inflammation. Am. J. Physiol. (Regul. Integrative Comp. Physiol.). 253:1987;R922-R928.
29. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
30. Morganti-Kossman M.C., Lenzlinger P.M., Hans V., Stahel P., Csuka E., Ammann E., Stocker R., Trentz O., Kossmann T. Production of cytokines following brain injury: beneficial and deleterious for the damage tissue. Mol. Psychiatry. 2:1997;133-136.
31. Nava F., Calapai G., Facciola G., Cuzzocrea S., Marciano M.C., De Sarro A., Caputi A.P. Effects of interleukin-10 on water intake, locomotory activity, and rectal temperature in rat treated with endotoxin. Int. J. Immunopharmacol. 19:1997;31-38.
32. Opp M.R., Smith E.M., Hughes T.K. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J. Neuroimmunol. 60:1995;165-168.
33. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. 83:1998;281-293.
34. Rennick D.M., Fort M.M., Davidson N.J. Studies with IL-10 -/- mice: an overview. J. Leukocyte Biol. 61:1997;389-396.
35. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
36. Williams K., Dooley N., Ulvestad E., Becher B., Antel J.P. IL-10 production by adult human derived microglial cells. Neurochem. Int. 29:1996;55-64.
37. Zhai Q.H., Futrell N., Chen F.J. Gene expression of IL-10 in relationship to TNF-α, IL-1β and IL-2 in the rat following middle cerebral artery occlusion. J. Neurol. Sci. 152:1997;119-124.
38. Zuckerman S.H., Shellhaas J., Butler L.D. Differential regulation of lipopolysaccharide-induced interleukin-1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur. J. Immunol. 19:1989;301-305.